Hybrid (Indica-leaning)
Beginner Friendly

Blue Cheese | Cannabis Strain Review & Effects

Blueberry x UK Cheese

Blue Cheese is a hybrid-leaning indica strain (Blueberry x UK Cheese) with THC levels of 15-20%. It features a Myrcene-dominant terpene profile and is known for relaxed and happy. Best used during the evening.

THC

15-20%

CBD

0-1%

Best Time

Evening

Primary Effects

RelaxedHappyEuphoricSleepyUplifted

Flavor Notes

Cheese, Blueberry, Sweet, Earthy

Aroma

Cheese aroma with blueberry and earthy notes

Research Sources

29 peer-reviewed studies

Verified Via

PubMed / DOI

Evidence

Research-Backed

Updated

December 2025

Every claim cites peer-reviewed research
How We Research

What is Blue Cheese?

Blue Cheese is a hybrid-leaning indica strain (Blueberry x UK Cheese) with THC levels of 15-20%. It features a Myrcene-dominant terpene profile and is known for relaxed and happy. Best used during the evening.

About Blue Cheese Strain

Blue Cheese is a indica-dominant hybrid cannabis strain created by crossing Blueberry x UK Cheese, bred by Big Buddha Seeds. Testing at 15-20% THC, Blue Cheese offers moderate to strong potency suitable for regular cannabis consumers.

Users of Blue Cheese commonly report feeling relaxed, happy, euphoric, sleepy. The effects often start with a wave of mental relaxation that gradually spreads throughout the body. As the high deepens, physical tension melts away, making it ideal for unwinding after a long day. Best enjoyed in the evening, this strain helps transition from the day's activities into a more relaxed state.

Medical cannabis patients frequently turn to Blue Cheese for relief from stress, anxiety, chronic pain, insomnia. Myrcene, the dominant terpene, is associated with sedative and muscle-relaxant properties that may enhance the strain's therapeutic potential.

Blue Cheese is considered beginner-friendly, making it accessible for those new to cannabis or with lower tolerance levels. Start with a small dose and wait at least 15-30 minutes before consuming more, especially when trying this strain for the first time. Common side effects may include dry mouth, dry eyes. Staying well-hydrated and having snacks on hand can help minimize discomfort.

The aroma of Blue Cheese is characterized by cheese, blueberry, earthy notes that create a distinctive sensory profile. On the palate, expect cheese, blueberry, sweet flavors that develop throughout each session. The myrcene-dominant terpene profile is largely responsible for these aromatic and flavor characteristics, contributing to the entourage effect that shapes the overall experience.

Related Reading

Commonly Used For

Patients often seek Blue Cheese for relief from the following conditions:

Note: These are commonly reported uses based on patient experiences. Individual results may vary. Always consult with a healthcare provider to determine if medical cannabis is appropriate for your specific condition.

Potential Side Effects

Be aware of these commonly reported side effects when using Blue Cheese:

Dry MouthDry Eyes

How to minimize side effects

  • Start with a low dose, especially if new to cannabis
  • Stay hydrated before, during, and after use
  • Use in a comfortable, familiar environment
  • Avoid mixing with alcohol or other substances

Terpene Profile

Myrcenedominant
Earthy, musky, clove-like~0.8%

Primary research: Sedation & Relaxation

Spicy, peppery, woody, clove-like~0.4%

Primary research: Anti-inflammatory

Limonenesecondary
Citrus, lemon, orange~0.2%

Primary research: THC Anxiety Reduction

Concentration Levels

Dominant (>1.0%)
Primary (0.5-1.0%)
Secondary (0.1-0.5%)
Trace (<0.1%)

Cannabinoid Profile

THCPsychoactive

15-20%

Pain Relief

0-1%

Seizure Reduction

Therapeutic Profile Matches

Based on Blue Cheese's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:

migraines

73%
Good Match
  • High myrcene content supports migraines & headaches
  • High beta-caryophyllene content supports migraines & headaches
  • thc dominant ratio matches profile

muscle spasms

68%
Good Match
  • High myrcene content supports muscle spasms & spasticity
  • High beta-caryophyllene content supports muscle spasms & spasticity
  • Best used evening, aligning with condition needs

ptsd

68%
Good Match
  • High myrcene content supports ptsd & trauma
  • High beta-caryophyllene content supports ptsd & trauma
  • thc dominant ratio matches profile

nausea

67%
Good Match
  • High beta-caryophyllene content supports nausea & appetite loss
  • High limonene content supports nausea & appetite loss
  • thc dominant ratio matches profile

multiple sclerosis

61%
Moderate Match
  • High myrcene content supports multiple sclerosis
  • High beta-caryophyllene content supports multiple sclerosis
  • Best used evening, aligning with condition needs

Match scores are theoretical

These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.

  1. 1

    Surendran S, et al. Myrcene-What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021

    Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.

  2. 2

    Johnson MB, et al. The Effects of β-myrcene on Simulated Driving and Divided Attention: A Double-Blind, Placebo-Controlled, Crossover Pilot Study Cannabis. 2023

    Found myrcene alone did not significantly impair simulated driving performance.

  3. 3

    do Vale TG, et al. Central effects of citral, myrcene and limonene, constituents of essential oil chemotypes from Lippia alba (Mill.) n.e. Brown Phytomedicine. 2002

    Demonstrated dose-dependent sedative and motor-relaxant effects of myrcene in mice.

  4. 4

    Lorenzetti BB, et al. Myrcene mimics the peripheral analgesic activity of lemongrass tea Journal of Ethnopharmacology. 1991

    Found peripheral analgesic activity in animal models.

  5. 5

    Liktor-Busa E, et al. Analgesic Potential of Terpenes Derived from Cannabis sativa Pharmacological Reviews. 2021

    Comprehensive review of cannabis terpene analgesic effects including myrcene.

  6. 6

    Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008

    Landmark paper: BCP directly activates CB2 receptors.

  7. 7

    Klauke AL, et al. The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain European Journal of Pain. 2014

    Showed dual mechanism for neuropathic pain relief.

  8. 8

    Bahi A, et al. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice Physiology & Behavior. 2014

    BCP reduced anxiety via CB2 receptor activation.

  9. 9

    Horvath B, et al. β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner Free Radical Biology and Medicine. 2012

    BCP reduced inflammation markers and oxidative stress.

  10. 10

    Tambe Y, et al. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, beta-caryophyllene Planta Medica. 1996

    BCP protected gastric mucosa in ulcer models.

  11. 11

    Tagen M, et al. Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol Drug and Alcohol Dependence. 2024

    Johns Hopkins study showing limonene specifically reduces THC-induced anxiety in humans.

  12. 12

    Vieira AJ, et al. Limonene: Aroma of innovation in health and disease Chemico-Biological Interactions. 2018

    Comprehensive review of limonene's anxiolytic and antidepressant effects.

  13. 13

    Kiecolt-Glaser JK, et al. Olfactory influences on mood and autonomic, endocrine, and immune function Psychoneuroendocrinology. 2008

    Lemon scent exposure improved mood and reduced norepinephrine.

  14. 14

    Sun J. D-Limonene: safety and clinical applications Alternative Medicine Review. 2007

    D-limonene showed gastroprotective effects and clinical safety.

  15. 15

    Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046

    Landmark paper first identifying and synthesizing THC.

  16. 16

    Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015

    Comprehensive review finding moderate evidence for chronic pain.

  17. 17

    Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Pain Physician. 2017

    Systematic review of clinical trials for neuropathic pain.

  18. 18

    Lutge EE, et al. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS Cochrane Database of Systematic Reviews. 2013

    Systematic review of cannabis for HIV/AIDS symptoms including appetite.

  19. 19

    Smith LA, et al. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy Cochrane Database of Systematic Reviews. 2015

    High-quality evidence for CINV efficacy.

  20. 20

    Kesner AJ, Lovinger DM. Cannabinoids, Endocannabinoids and Sleep Frontiers in Molecular Neuroscience. 2020

    Review of THC effects on sleep architecture.

  21. 21

    Novotna A, et al. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis European Journal of Neurology. 2011

    Phase III trial showing efficacy for MS spasticity.

  22. 22

    Silvestro S, et al. Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease Molecules. 2020

    Comprehensive review of CBD's therapeutic applications and molecular targets.

  23. 23

    Thiele EA, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Lancet. 2018

    Phase III trial leading to FDA approval of Epidiolex.

  24. 24

    Devinsky O, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurology. 2016

    Open-label trial showing 36.5% reduction in seizures.

  25. 25

    Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019

    79.2% of patients reported reduced anxiety within first month.

  26. 26

    Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients Neuropsychopharmacology. 2011

    CBD reduced anxiety in simulated public speaking test.

  27. 27

    Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation Bioorganic & Medicinal Chemistry. 2015

    Review of CBD's anti-inflammatory mechanisms.

  28. 28

    Shannon S, et al. Cannabidiol in Anxiety and Sleep: A Large Case Series Permanente Journal. 2019

    66.7% of patients reported improved sleep in this anxiety and sleep study.

  29. 29

    Urits I, et al. Use of cannabidiol (CBD) for the treatment of chronic pain Best Practice & Research Clinical Anaesthesiology. 2020

    Comprehensive review of CBD for chronic pain management.

Research Verification

All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.

Frequently Asked Questions

What are the effects of Blue Cheese?

Blue Cheese is known for producing relaxed, happy, euphoric, sleepy effects. As a hybrid indica, it's typically best suited for evening use. This strain is considered beginner-friendly.

What conditions might Blue Cheese help with?

Blue Cheese is commonly used by patients seeking relief from stress, anxiety, chronic pain, insomnia. Always consult with a healthcare provider before using cannabis for medical purposes.

How strong is Blue Cheese?

Blue Cheese is considered moderately potent with THC levels typically ranging from 15-20%. Despite its potency, it's considered accessible for most users when dosed appropriately.

What does Blue Cheese taste and smell like?

Blue Cheese features cheese, blueberry, sweet flavors with a cheese, blueberry, earthy aroma. Its unique terpene combination creates a memorable sensory experience.

What are the side effects of Blue Cheese?

Common side effects include dry mouth, dry eyes. Staying hydrated and starting with a low dose can help minimize these effects.

Quick Facts

Type
Hybrid (Indica-leaning)
Genetics
Blueberry x UK Cheese
Breeder
Big Buddha Seeds
Genetic Family
Blueberry Family
Best Time of Use
Evening
Availability
moderate
Grow Difficulty
moderate
Experience Level
Beginner Friendly

Want to try Blue Cheese? Get your medical marijuana card today.

Get Your Card

Similar Strains

If you like Blue Cheese, try these

UK CheeseBlueberryBlue Dream

Related by Genetics

Educational Information

This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.

Strain Variability

Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.

Beyond Indica/Sativa

Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.

Understanding Therapeutic Profiles

Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.

Learn About Therapeutic Profiles